Inhibitory effects of emodin, baicalin, schizandrin and berberine onhefAgene: Treatment ofHelicobacter pylori-induced multidrug resistance
Authors:
Open Access
- 1 January 2015
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (14) , 4225-31
Abstract
To investigate the inhibitory effects of emodin, baicalin, etc. on the hefA gene of multidrug resistance (MDR) in Helicobacter pylori (H. pylori). The double dilution method was used to screen MDR H. pylori strains and determine the minimum inhibitory concentrations (MICs) of emodin, baicalin, schizandrin, berberine, clarithromycin, metronidazole, tetracycline, amoxicillin and levofloxacin against H. pylori strains. After the screened MDR stains were treated with emodin, baicalin, schizandrin or berberine at a 1/2 MIC concentration for 48 h, changes in MICs of amoxicillin, tetracycline, levofloxacin, metronidazole and clarithromycin were determined. MDR strains with reduced MICs of amoxicillin were selected to detect the hefA mRNA expression by real-time quantitative PCR. A total of four MDR H. pylori strains were screened. Treatment with emodin, baicalin, schizandrin and berberine significantly decreased the MICs of amoxicillin and tetracycline against some strains, decreased by 1 to 2 times, but did not significantly change the MICs of clarithromycin, levofloxacin, and metronidazole against MDR strains. In the majority of strains with reduced MICs of amoxicillin, hefA mRNA expression was decreased; one-way ANOVA (SPSS 12.0) used for comparative analysis, P < 0.05. Emodin, baicalin, schizandrin and berberine significantly decreased the MICs of amoxicillin and tetracycline against some H. pylori strains, possibly by mechanisms associated with decreasing hefA mRNA expression.Keywords
This publication has 20 references indexed in Scilit:
- Pathogenesis of Helicobacter pylori InfectionHelicobacter, 2013
- Long‐term Follow‐up Helicobacter Pylori Reinfection Rate and Its Associated Factors in KoreaHelicobacter, 2012
- Anticancer potential of emodinBioMedicine, 2012
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus ReportGut, 2012
- Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pyloriActa Biomaterialia, 2011
- Molecular characterization and susceptibility testing of Helicobacter pylori strains isolated in western ArgentinaInternational Journal of Infectious Diseases, 2010
- Screening test for anti-Helicobacter pyloriactivity of traditional Chinese herbal medicinesWorld Journal of Gastroenterology, 2010
- Influence of efflux pump inhibitors on the multidrug resistance ofHelicobacter pyloriWorld Journal of Gastroenterology, 2010
- Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in GermanyJournal of Antimicrobial Chemotherapy, 2009
- Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistanceWorld Journal of Gastroenterology, 2008